13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

36 trials found

diseases per page:

Showing 1 to 10 of 36 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-002700-39-HR (EUCTR)	29/11/2021	06/12/2021	Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with mu ...	A 2-year randomized, 3-arm, double-blind, non-inferiority study comparing the efficacy and safety of ...	Multiple Sclerosis in pediatric patients MedDRA version: 20.1;Level: PT;Classification code 10028245 ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB Trade ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	United States;Serbia;Portugal;Taiwan;Estonia;Slovakia;Spain;Ukraine;Chile;Israel;Russian Federation; ...
2	EUCTR2020-002700-39-SK (EUCTR)	04/10/2021	16/06/2021	Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with mu ...	A 2-year randomized, 3-arm, double-blind, non-inferiority study comparing the efficacy and safety of ...	Multiple Sclerosis in pediatric patients MedDRA version: 20.1;Level: PT;Classification code 10028245 ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB Trade ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	United States;Portugal;Serbia;Taiwan;Estonia;Slovakia;Spain;Ukraine;Chile;Israel;Russian Federation; ...
3	EUCTR2020-002700-39-PL (EUCTR)	29/09/2021	10/08/2021	Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with mu ...	A 2-year randomized, 3-arm, double-blind, non-inferiority study comparing the efficacy and safety of ...	Multiple Sclerosis in pediatric patients MedDRA version: 20.1;Level: PT;Classification code 10028245 ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB Trade ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Taiwan;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Chile; ...
4	EUCTR2020-002700-39-DE (EUCTR)	10/09/2021	20/05/2021	Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with mu ...	A 2-year randomized, 3-arm, double-blind, non-inferiority study comparing the efficacy and safety of ...	Multiple Sclerosis in pediatric patients MedDRA version: 20.1;Level: PT;Classification code 10028245 ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB Trade ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Taiwan;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Chile; ...
5	EUCTR2020-002700-39-LV (EUCTR)	09/09/2021	28/07/2021	Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with mu ...	A 2-year randomized, 3-arm, double-blind, non-inferiority study comparing the efficacy and safety of ...	Multiple Sclerosis in pediatric patients MedDRA version: 20.1;Level: PT;Classification code 10028245 ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB Trade ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	95	Phase 3	Serbia;United States;Portugal;Taiwan;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Chile; ...
6	EUCTR2020-002700-39-PT (EUCTR)	03/09/2021	24/05/2021	Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with mu ...	A 2-year randomized, 3-arm, double-blind, non-inferiority study comparing the efficacy and safety of ...	Multiple Sclerosis in pediatric patients MedDRA version: 20.1;Level: PT;Classification code 10028245 ...	Trade Name: Kesimpta 20 mg solution for injection in pre-filled pen Product Name: ofatumumab Product Co ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;Portugal;United States;Taiwan;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Chile; ...
7	EUCTR2019-001341-40-LV (EUCTR)	02/09/2021	28/07/2021	An open-label study evaluating ofatumumab treatment effectiveness and PROs in subjects with RMS tran ...	A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiven ...	Multiple sclerosis MedDRA version: 20.0;Level: PT;Classification code 10048393;Term: Multiple sclero ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	550	Phase 3	United States;Portugal;Estonia;Saudi Arabia;Slovakia;Greece;Spain;Lebanon;Russian Federation;Italy;S ...
8	EUCTR2019-001341-40-SI (EUCTR)	20/08/2021	12/07/2021	An open-label study evaluating ofatumumab treatment effectiveness and PROs in subjects with RMS tran ...	A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiven ...	Multiple sclerosis MedDRA version: 20.0;Level: PT;Classification code 10048393;Term: Multiple sclero ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	555	Phase 3	United States;Portugal;Saudi Arabia;Estonia;Slovakia;Greece;Spain;Lebanon;Russian Federation;Switzer ...
9	EUCTR2020-002700-39-AT (EUCTR)	17/08/2021	07/06/2021	Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with mu ...	A 2-year randomized, 3-arm, double-blind, non-inferiority study comparing the efficacy and safety of ...	Multiple Sclerosis in pediatric patients MedDRA version: 20.1;Level: PT;Classification code 10028245 ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB Trade ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Portugal;Serbia;United States;Taiwan;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Chile; ...
10	EUCTR2020-002700-39-LT (EUCTR)	10/08/2021	07/06/2021	Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with mu ...	A 2-year randomized, 3-arm, double-blind, non-inferiority study comparing the efficacy and safety of ...	Multiple Sclerosis in pediatric patients MedDRA version: 20.1;Level: PT;Classification code 10028245 ...	Trade Name: Kesimpta Product Name: ofatumumab Product Code: OMB157 INN or Proposed INN: OFATUMUMAB Trade ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Taiwan;Estonia;Slovakia;Spain;Ukraine;Russian Federation;Israel;Chile; ...

First Previous1 2 3 4Next Last